e-SPACE Cardio-Renal-Metabolic 2024

Published: 29 March 2024

  • Views:

    Views Icon 489

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) 2024.

 

A thoughtfully curated programme supported the exploration of how leading experts, in cardiology, nephrology and diabetology, treat the interrelated diseases.

 

This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Related sessions to e-SPACE Cardio-Renal-Metabolic 2024:

e-SPACE Cardio-Renal-Metabolic 2024 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
  • Describe the complexity and interlink between the three conditions
  • Discuss existing guidelines and best approaches for screening patients
  • Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
  • Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes

Target Audience

  • Cardiologists
  • Nephrologists
  • Diabetologists
  • General Practitioners (GPs)
  • HF Specialists
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day One

6 sessions
Plenary Session 1 – Multidisciplinary implementation strategies Watch now
Keynote Session – KDIGO guideline updates 2024 Watch now
Plenary Session 2 – Guideline directed therapy for CRM disease: the evidence base Watch now
Plenary Session 3 – Managing the patients with CRM: who gets what, when and why? Watch now
Plenary Session 4 – Weight homeostasis management in CRM disease (Organised with support from Charité Friends & Sponsors Trust) Watch now
Plenary Session 5 – CRM disease: epidemiology and pathophysiology Watch now

Part 2

Day Two

6 sessions
Plenary Session 6 – Anaemia and iron deficiency Watch now
Practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk Watch now
Plenary Session 7 – Clinical presentations and treatment across the patient journey: focus on CKD and CVD Watch now
Plenary Session 8 – Early intervention and intensive management Watch now
Effects of GLP- 1RA on kidney outcomes in CKD and T2D Watch now
Plenary Session 9 – Precision medicine in CRM Watch now

Faculty Biographies

Paul Stevens

Paul Stevens

Consultant Nephrologist

Dr Paul Stevens is a Consultant Nephrologist at East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.

Dr Stevens is interested in the evaluation of kidney function, the variability of biochemical indicators of complications of kidney disease, the epidemiology of acute and chronic kidney disease and development of information technology based solutions for identification of kidney disease.

View full profile
Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…

View full profile
Josef Coresh

Josef Coresh

Professor of Epidemiology, Biostatistics and Medicine

Dr Josef Coresh is a Professor of Epidemiology, Biostatistics and Medicine at Johns Hopkins Bloomberg School of Public Health, Maryland, US.

Dr Coresh is an expert in kidney and cardiovascular disease epidemiology, having co-authored over 1,000 research articles cited over 100,000 times.

View full profile
Navdeep Tangri

Navdeep Tangri

Professor of Medicine in the Division of Nephrology

Dr Navdeep Tangri is a Professor of Medicine in the Division of Nephrology at University of Manitoba, Winnipeg, CA.

Dr Tangri's research programme is focused on the clinical management of patients with advanced chronic kidney disease. He developed the kidney failure risk equation (KFRE) to predict the need for dialysis in patients with chronic kidney disease.

View full profile
Wenjun Ju

Wenjun Ju

Translational Scientist

Dr Wenjun Ju is a Translational Scientist in the field of nephrology at University of Michigan Medical School, Michigan, US.

Dr Ju's expertise is in drug target identification and leading the discovery and development of non-invasive biomarkers for disease progression and treatment response

View full profile

Comments

You must be to comment. If you are not registered, you can register here.